171 related articles for article (PubMed ID: 18765269)
1. Discovery of new inhibitors of aldo-keto reductase 1C1 by structure-based virtual screening.
Brozic P; Turk S; Lanisnik Rizner T; Gobec S
Mol Cell Endocrinol; 2009 Mar; 301(1-2):245-50. PubMed ID: 18765269
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
Turk S; Kovac A; Boniface A; Bostock JM; Chopra I; Blanot D; Gobec S
Bioorg Med Chem; 2009 Mar; 17(5):1884-9. PubMed ID: 19223185
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
Gobec S; Brozic P; Rizner TL
Bioorg Med Chem Lett; 2005 Dec; 15(23):5170-5. PubMed ID: 16183274
[TBL] [Abstract][Full Text] [Related]
4. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E
J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual screening.
Kovac A; Konc J; Vehar B; Bostock JM; Chopra I; Janezic D; Gobec S
J Med Chem; 2008 Dec; 51(23):7442-8. PubMed ID: 19053785
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening.
Markt P; McGoohan C; Walker B; Kirchmair J; Feldmann C; De Martino G; Spitzer G; Distinto S; Schuster D; Wolber G; Laggner C; Langer T
J Chem Inf Model; 2008 Aug; 48(8):1693-705. PubMed ID: 18637674
[TBL] [Abstract][Full Text] [Related]
7. Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
Kuck D; Singh N; Lyko F; Medina-Franco JL
Bioorg Med Chem; 2010 Jan; 18(2):822-9. PubMed ID: 20006515
[TBL] [Abstract][Full Text] [Related]
8. Derivatives of pyrimidine, phthalimide and anthranilic acid as inhibitors of human hydroxysteroid dehydrogenase AKR1C1.
Brozic P; Cesar J; Kovac A; Davies M; Johnson AP; Fishwick CW; Lanisnik Rizner T; Gobec S
Chem Biol Interact; 2009 Mar; 178(1-3):158-64. PubMed ID: 19007763
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
[TBL] [Abstract][Full Text] [Related]
10. Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3.
Beranič N; Gobec S; Rižner TL
Chem Biol Interact; 2011 May; 191(1-3):227-33. PubMed ID: 21182831
[TBL] [Abstract][Full Text] [Related]
11. Design and development of novel inhibitors of aldo-ketoreductase 1C1 as potential lead molecules in treatment of breast cancer.
Verma P; Hassan MI; Singh A; Singh IK
Mol Cell Biochem; 2021 Aug; 476(8):2975-2987. PubMed ID: 33770316
[TBL] [Abstract][Full Text] [Related]
12. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
Kumar A; Chaturvedi V; Bhatnagar S; Sinha S; Siddiqi MI
J Chem Inf Model; 2009 Jan; 49(1):35-42. PubMed ID: 19063713
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints.
Kumar A; Siddiqi MI
J Mol Graph Model; 2008 Nov; 27(4):476-88. PubMed ID: 18829358
[TBL] [Abstract][Full Text] [Related]
14. Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches.
Mochalkin I; Miller JR; Narasimhan L; Thanabal V; Erdman P; Cox PB; Prasad JV; Lightle S; Huband MD; Stover CK
ACS Chem Biol; 2009 Jun; 4(6):473-83. PubMed ID: 19413326
[TBL] [Abstract][Full Text] [Related]
15. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
16. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
McLean LR; Zhang Y; Li H; Li Z; Lukasczyk U; Choi YM; Han Z; Prisco J; Fordham J; Tsay JT; Reiling S; Vaz RJ; Li Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6717-20. PubMed ID: 19836948
[TBL] [Abstract][Full Text] [Related]
17. Scoring ligand similarity in structure-based virtual screening.
Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
[TBL] [Abstract][Full Text] [Related]
18. Smaller is better for antibiotic discovery.
Waldrop GL
ACS Chem Biol; 2009 Jun; 4(6):397-9. PubMed ID: 19537754
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening.
Postigo MP; Guido RV; Oliva G; Castilho MS; da R Pitta I; de Albuquerque JF; Andricopulo AD
J Chem Inf Model; 2010 Sep; 50(9):1693-705. PubMed ID: 20695479
[TBL] [Abstract][Full Text] [Related]
20. Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors.
Yang H; Shen Y; Chen J; Jiang Q; Leng Y; Shen J
Eur J Med Chem; 2009 Mar; 44(3):1167-71. PubMed ID: 18653260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
